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   Calcium regulation hormones， parathyroid hormone （PTH）， 1，25－dihydroxyvitamin D （1，25
（OH）2D3） and calcitonin （CT） were measured and calcium and phosphate metabolism investigated
in primary hyperparathyroidism （PHP， n＝＝15）， normocalcemic idiopathic hypercalciuria （IHC，
n＝12） and related metabolic disorders of calcium， and pathogenesis of hypercalciuria was discussed．
Calcium－47 dynamic study using whole body counter consisting of intestinal absorption and body
retention rates of calcium was also applied in those patients．
    1． Elevations ofserum 1，25（OH）2D3 and urinary calcium excretion were se¢n as a common feature
between PHP and IHC and increased intestinal calcium absorption and decreased serum phosphorus
as a similar directional change．
   2． Biochemical differences were seen’between adenoma and hyperplasia in PHP． ln hyperplasia，
while serum 1，25（OH）2D3 increased significantly， serum phosphate and urinary excretion of calcium
increased and PTH decreased， but these were not significant changes． ln adenoma， alka！ine phos－
phatase significantly increased．
   3．In PHP， excssive production of Pr且stimulates．production of 1，25（OH）2D3 in the kidney，
which enhances intestinal absorption o£ calcium． Hypophosphatemia had no effects on serum 1，25
（OH）2D3 and utinary excretion of calcium．
   4． ln IKC， although the subgroup， either absDrptive or reabsorptive， should be classified，
elevation of serum 1，25（OH）2D3 was a characteristic feature， which enhanced intestinal absorption
of calcium， resulting in increased urinary excretion of calcium， However， increased levels of 1，25
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（OH）2D3 did not para11el the amount of intestinal absorption． Since there was a good correlation
between serum 1，25（OH）2D3 and phosphorus or urinary excretion of caicium and serum phosphorus，
hypohophosphaternia is a factor which stimulates the production of 1，25（OH）2D3 in the kidney．
PTH levels were within normal Iimits．
  5． Serurn CT levels were norma1 in those patients in spite of alterations of PTH and 1，25
（OH），D，．
  6． Except that elevations of serum calcium and PTH were seen in PHP， the level of 1，25
（OH）2D3 in the hyperplasia group of PHP was similar to that in IHC． Levels of serum phospho－
rus and the amount of urinary calcium excretion in hyperplasia group showed a similar directional
changes to those in IHC． It is suggested that an intermediate form possibly exists between reabso－
























































：量，％TR．P， PTH， vit D3， CT， alkaline phospha－
taseの検査項目を比較した．なお， PTH， vit D3，
CTの3種類の測定ができたのは最近の3年間の症例
に限られた．入院症例については原則としてCa制限
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10・5 mg／loo ml，血中P2．5～4．5 ng／loo ml，尿中




り測定した，正常値はPTH＜o．5 ng／ml， GT o．025
～0．090ng／mlであった．
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Fig． 4． Relation＄hiP between urinary exeretion of ca！cium and serum 1，25（OH）2D3．
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Fig． 7． Relationship between serum PTH and
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Fig． 9． Body retention study of 47－calcium in
    healthy controls and’patients with me－
    tabolic disorders of calcium．
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Fig． 10．’ Relationship between intestinal calcium absorption and serum 1，25（OH）2D3 level in
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． Primary hyperparathyroidism （n＝5， r＝一〇．85， y＝118．10－O．09x）
i Hypercatciuria （n＝7， r＝O．28， y＝62．49＋O．03x）
S Rena［ stones without hypercatciuria
e Hypercatcemia atter renal transp［antation
．
Fig， 12．
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Relationship between body retention of calcium and urinary calcium excretion in
patients with metabolic disorders of calcium．
                  Table 2．
COMPARISON OF HORMONAL AND BIOCHEMICAL FEA丁URES BETWEENPRIMARY HYPERPARATHYROIDISM AND HYPERCALCI URIA
Primary hyperparathyroidismHyperca（ciuria Betweentwo groups
Serum i－PTH
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  Fig． 14． Pathogenesis of primary absorptive （［‘idiopathic’；） hypercalciuria．
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  Fig． 15． Pathogenesis of reabsorptive hypercalciuria （renal calcium leak）．
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